Kisunla
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Kisunla, covering 2024-07-02 to 2026-02-26. Get the full timeline:
Most recent: EMA Authorised: Kisunla (donanemab) — Eli Lilly Nederland B.V.
3 regulatory and trial events tracked for Kisunla, covering 2024-07-02 to 2026-02-26. Get the full timeline:
Most recent: EMA Authorised: Kisunla (donanemab) — Eli Lilly Nederland B.V.